What fluvoxamine (Luvox) dose is equivalent to 20 mg fluoxetine (Prozac) for antidepressant effect?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 10, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Fluvoxamine 100-150 mg daily is approximately equivalent to fluoxetine 20 mg daily for antidepressant effect.

Based on the most rigorous dose-equivalence research, fluvoxamine 143 mg/day is equivalent to fluoxetine 40 mg/day 1, which translates to approximately 71.5 mg/day fluvoxamine being equivalent to fluoxetine 20 mg/day. However, given practical dosing considerations and guideline recommendations, the appropriate clinical equivalent is fluvoxamine 100-150 mg/day for fluoxetine 20 mg/day.

Evidence-Based Dose Equivalence

The 2015 systematic analysis of 83 randomized controlled trials (14,131 participants) calculated weighted mean dose ratios from flexible-dose trials 1. This methodology found:

  • Fluoxetine 40 mg/day = Fluvoxamine 143.3 mg/day
  • Therefore: Fluoxetine 20 mg/day ≈ Fluvoxamine 71.5 mg/day (by direct proportion)

Practical Clinical Dosing

The calculated 71.5 mg dose is not clinically practical. Multiple guidelines consistently recommend:

  • Fluvoxamine starting dose: 50 mg twice daily (100 mg/day total) 2, 3
  • Fluvoxamine effective dose range: 100-150 mg/day 2
  • Fluvoxamine maximum dose: 300 mg/day 2, 3

The 2003 Japanese cohort study of 72 depression patients demonstrated that high-dose fluvoxamine (100-150 mg/day) achieved 73.7% improvement versus only 47.1% with low-dose (50-75 mg/day), a statistically significant difference (P=0.0282) 4. This supports using 100-150 mg/day as the therapeutic target.

Recommended Conversion Algorithm

When switching from fluoxetine 20 mg/day to fluvoxamine:

  1. Start fluvoxamine at 50 mg twice daily (100 mg/day total) - this is the standard guideline-recommended starting dose 2, 3

  2. Titrate to 150 mg/day if needed after 1-2 weeks based on response and tolerability 2

  3. Allow 6 weeks at therapeutic dose before determining efficacy, as >80% of responders show improvement by week 6 4

  4. Consider fluoxetine's long half-life - fluoxetine has a 1-3 day half-life with active metabolite norfluoxetine having 7-15 days 5. When switching, you can either:

    • Cross-taper over 1-2 weeks
    • Stop fluoxetine and start fluvoxamine immediately (given fluoxetine's long washout)

Important Prescribing Differences

Fluvoxamine has greater potential for drug-drug interactions than fluoxetine 6:

  • Fluvoxamine inhibits CYP1A2, CYP2C19, CYP2C9, CYP3A4, and CYP2D6
  • Exercise caution with alprazolam or triazolam - reduce benzodiazepine dose by 50% 2
  • Fluoxetine primarily inhibits CYP2D6

Fluvoxamine requires twice-daily dosing (50 mg BID to start) versus fluoxetine's once-daily dosing 2, 3.

Fluvoxamine has higher discontinuation syndrome risk than fluoxetine due to shorter half-life 6. Taper slowly when discontinuing.

Clinical Equivalence Data

Head-to-head trials show comparable efficacy:

  • The 1996 US double-blind trial (100 patients) found fluvoxamine 100-150 mg/day and fluoxetine 20-80 mg/day equally effective (both groups: 60% improvement in HAM-D scores, 84% completion rate) 7
  • The 2003 multinational trial (184 patients) found fluvoxamine 100 mg/day and fluoxetine 20 mg/day had similar overall efficacy, though fluvoxamine showed faster onset at week 2 8

The bottom line: Start with fluvoxamine 100 mg/day (50 mg BID) when switching from fluoxetine 20 mg/day, and titrate to 150 mg/day if needed for optimal response.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.